Abstract
The purpose of this paper was to provide evidence for the reintroduction of simultaneously performed fluorescein angiography and electroretinography in the detection of diabetic retinopathy. ERG observations were made in conjunction with fluorescein angiography of 13 patients suffering from type I diabetes mellitus for five to 13 years. Only patients without any fluorescein leakage during angiography and without any morphologic changes in the fundus were involved in the study. Gold foil electrodes were used for recording. A stroboscopic lamp provided flashing light stimulation through a monochromatic blue filter. Intravenous fluorescein administration caused an immediate reduction in the ERG response. This reduction was seen both in the control subjects and in diabetes patients. In the control group, the reduction was over in 30-45 min, while in the diabetes group a considerable amplitude elevation was seen in all recordings between 15 and 60 min post-fluorescein. In the adaptation control group, where only repeated ERG recordings were employed every 15 min, a slight decrease in the a wave and a slight elevation of the b wave were observed during the whole recording period. No complaints or side-effects were detected during the observations. As all the patients displayed a normal fluorescein angiography besides elevated b wave after fluorescein administration, and this elevation was seen exclusively in the diabetic group, our study raises the possibility that this diagnostic method can be used in the detection of diabetic retinopathy.
Similar content being viewed by others
References
Hayreh SS. Recent advances in fluorescein fundus angiography. Br J Ophthalmol. 1974; 58: 391–412.
Cavallerano AA. Ophthalmic fluorescein angiography. Optom Clin 1996; 5: 1–23.
Cunha-Vaz JG, Farina de Abreu JR, Campos AJ. Early breakdown of the blood-retinal barrier in diabetes, Br J Ophthalmol. 1975; 59: 649–56.
Schalnus R, Ohrloff C. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry. Ophthalmic Res. 1995; 27 Suppl 1: 116–23.
Götterberg M. The electroretinogram in diabetic retinopathy. A clinical study and a critical survey. Arch Ophthalmol. (Copenh.) 1974; 52: 521–33.
Parisi V, Uccioli L. Monticone G, Parisi L, Manni G, Ippoliti D, Menzinger G, Bucci MG. Electrophysiological assessment of visual function in IDDM patients. Electroencephalogr Clin Neurophysiol. 1997; 104: 171–9.
Juen S, Kieselbach GF. Electrophysiological changes in juvenile diabetics without 6 retinopathy. Arch Ophthalmol. 1990; 108: 372–75.
Yoshida A, Kojima M, Ogasawara H, Ishiko S. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy. Ophthalmology 1991; 98: 1266–71.
Simonsen SE. The value of oscillatory potential in selecting juvenile diabetic patients at risk of developing proliferative retinopathy. Acta Ophthalmol. 1980; 58: 865–77.
Bresnick, GH, Palta M. Oscillatory potential amplitudes. Relation to severity of diabetic retinopathy. Arch Ophthalmol. 1987; 105: 929–33.
Kuwaba T, Gorin RA. Retinal damage by visible light. An electron microscopic study. Arch Ophthalmol. 1968; 72: 69.
Valenzeno DP, Pooler JP. Phototoxicity, the neglected factor. JAMA 1979; 242: 453–4.
Tamai M, Mizuno K. Electroretinogram changes after fluorescein injection: a new method to evaluate blood-retinal barrier dysfunction. Invest Ophthalmol Vis Sci 1981; 20: 272–6.
Bartz-Schmidt KU, Walter P, Krott R, Brunner R, Esser P, Heimann K. Effekte der Fluorescein-und Indocyaningrun-Angiographie auf den Verlauf der Dunkeladaptation und das Elektroretinogramm. Klin Monatsbl. Augenheilkd 1996; 208: 224–8.
Putting BJ, Zweypfenning RC, Vrensen GF, Oosterhuis JA, van Best JA. Dysfunction and repair of the blood-retina barrier following white light exposure: a fluorophotometric and histologic study. Exp Eye Res. 1992; 54: 133–41.
Putting BJ, Zweypfenning RC, Vrensen GF, Oosterhuis JA, van Best JA. Blood-retinal barrier dysfunction at the pigment epithelium induced by blue light. Invest Ophthalmol Vis Sci 1992; 33: 3385–93.
Rights and permissions
About this article
Cite this article
Janáky, M., Fülöp, Z. & Benedek, G. Fluorescein-ERG, a sensitive method for the detection of vascular damage in diabetic patients. Doc Ophthalmol 98, 117–126 (1999). https://doi.org/10.1023/A:1002053426084
Issue Date:
DOI: https://doi.org/10.1023/A:1002053426084